BCL-2 overexpression attenuates p53 stabilization and activation following RiBi inhibitors treatment

ABSTRACT: RNA-seq experiment performed in SUDHL-5 cells incubated with RiBi inhibitors (Doxorubicin, Actinomycin D, CX-5461) for 6h in the presence or absence of BCL-2.

INSTRUMENT(S): Illumina Hi-Seq 2000, Illumina HiSeq 2000

ORGANISM(S): Homo sapiens

SUBMITTER:  

PROVIDER: E-MTAB-14977 | biostudies-arrayexpress |

SECONDARY ACCESSION(S): ERP170864

REPOSITORIES: biostudies-arrayexpress